Search research articles
Contact Us
Filters
Showing results (21-30 of 56) with videos related to
Page
of 6
Sort By:
Respiratory Research
|
July 5, 2022
Decline in forced vital capacity in subjects with systemic sclerosis-associated interstitial lung disease in the SENSCIS trial compared with healthy reference subjects
Toby M Maher, Arnaud Bourdin, Elizabeth R Volkmann, et al.
Rheumatology (Oxford, England)
|
November 6, 2020
Disease frequency, patient characteristics, comorbidity outcomes and immunosuppressive therapy in systemic sclerosis and systemic sclerosis-associated interstitial lung disease: a US cohort study
Qiang Li, Laura Wallace, Padmaja Patnaik, et al.
Annals of the New York Academy of Sciences
|
October 31, 2025
Mycoplasma agassizii Multilocus Sequence Typing Using Nanopore Sequencing: Insights Into Genetic Diversity and Isolate Characterization
Carla Cacciotto, Rosanna Zobba, Manuel Louro, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam
|
June 6, 2013
Brazilian green propolis compared to miconazole gel in the treatment of Candida-associated denture stomatitis
Hermínia Marques Capistrano, Eliene Magda de Assis, Rosana Maria Leal, et al.
The Journal of General Virology
|
February 28, 2015
Gammaherpesviruses and canine lymphoma: no evidence for direct involvement in commonly occurring lymphomas
Elspeth M Waugh, Alice Gallagher, Karen A McAulay, et al.
Arthritis Research & Therapy
|
March 22, 2025
Trajectories of forced vital capacity in patients with systemic sclerosis-associated interstitial lung disease
Oliver Distler, Madelon C Vonk, Arata Azuma, et al.
Veterinary and Comparative Oncology
|
October 17, 2020
Canine lymphoma and vector-borne diseases: Molecular and serological evaluation of a possible complicity
Joaquim Henriques, Ricardo Felisberto, Bruno Almeida, et al.
ACR Open Rheumatology
|
July 19, 2022
Effect of Nintedanib on Progression of Systemic Sclerosis-Associated Interstitial Lung Disease Over 100 Weeks: Data From a Randomized Controlled Trial
Shervin Assassi, Oliver Distler, Yannick Allanore, et al.
Oncology Reports
|
January 1, 2010
Identification of a 0.4 Kb deletion region in 10q26 associated with endometrial carcinoma
Margarida Alves, Isabel Carreira, Paulo Liberato, et al.
RMD Open
|
February 23, 2025
Continued nintedanib in patients with systemic sclerosis-associated interstitial lung disease: 3-year data from SENSCIS-ON
Yannick Allanore, Madelon C Vonk, Oliver Distler, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 56) with videos related to
Sort By:
Page
of 6
Respiratory Research
|
July 5, 2022
Decline in forced vital capacity in subjects with systemic sclerosis-associated interstitial lung disease in the SENSCIS trial compared with healthy reference subjects
Toby M Maher, Arnaud Bourdin, Elizabeth R Volkmann, et al.
Rheumatology (Oxford, England)
|
November 6, 2020
Disease frequency, patient characteristics, comorbidity outcomes and immunosuppressive therapy in systemic sclerosis and systemic sclerosis-associated interstitial lung disease: a US cohort study
Qiang Li, Laura Wallace, Padmaja Patnaik, et al.
Annals of the New York Academy of Sciences
|
October 31, 2025
Mycoplasma agassizii Multilocus Sequence Typing Using Nanopore Sequencing: Insights Into Genetic Diversity and Isolate Characterization
Carla Cacciotto, Rosanna Zobba, Manuel Louro, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam
|
June 6, 2013
Brazilian green propolis compared to miconazole gel in the treatment of Candida-associated denture stomatitis
Hermínia Marques Capistrano, Eliene Magda de Assis, Rosana Maria Leal, et al.
The Journal of General Virology
|
February 28, 2015
Gammaherpesviruses and canine lymphoma: no evidence for direct involvement in commonly occurring lymphomas
Elspeth M Waugh, Alice Gallagher, Karen A McAulay, et al.
Arthritis Research & Therapy
|
March 22, 2025
Trajectories of forced vital capacity in patients with systemic sclerosis-associated interstitial lung disease
Oliver Distler, Madelon C Vonk, Arata Azuma, et al.
Veterinary and Comparative Oncology
|
October 17, 2020
Canine lymphoma and vector-borne diseases: Molecular and serological evaluation of a possible complicity
Joaquim Henriques, Ricardo Felisberto, Bruno Almeida, et al.
ACR Open Rheumatology
|
July 19, 2022
Effect of Nintedanib on Progression of Systemic Sclerosis-Associated Interstitial Lung Disease Over 100 Weeks: Data From a Randomized Controlled Trial
Shervin Assassi, Oliver Distler, Yannick Allanore, et al.
Oncology Reports
|
January 1, 2010
Identification of a 0.4 Kb deletion region in 10q26 associated with endometrial carcinoma
Margarida Alves, Isabel Carreira, Paulo Liberato, et al.
RMD Open
|
February 23, 2025
Continued nintedanib in patients with systemic sclerosis-associated interstitial lung disease: 3-year data from SENSCIS-ON
Yannick Allanore, Madelon C Vonk, Oliver Distler, et al.
Page
of 6